BloodThinnerHelp.com reports today on the latest developments in the Xarelto litigation. Recently, the manufacturers of Xarelto, Bayer AG and Johnson & Johnson’s pharmaceutical department, Janssen Pharmaceuticals, have been sued in federal court in the Eastern District of New York by a woman in Texas who alleges that because of the manufacturer’s lack of warning regarding Xarelto’s side effects and the lack of sufficient safety testing on the drug, she suffered serious injuries. The complaint is listed under federal court docket number 1:14-CV-04524 and has been transferred to the Xarelto MDL.
Lawsuit Alleges Manufacturers Concealed Xarelto Side Effects
The FDA approved Xarelto in 2011 for use in the United States. Since its approval, Xarelto has been marketed as a more convenient alternative to the traditionally prescribed blood thinner Warfarin because of Xarelto’s uniformed dosing and lack of required blood monitoring. Xarelto was approved to treat patients who suffered from atrial fibrillation, deep vein thrombosis, and in patients who have recently undergone knee or hip replacement surgeries. Despite these conveniences, as the complaint alleges, Xarelto’s manufacturers failed to warn doctors and patients that there is no antidote available to reverse the anti-coagulation effects that Xarelto causes, whereas the effects of Warfarin can be counteracted by administering Vitamin K.
In this case, the plaintiff was prescribed Xarelto by her doctor to prevent blood clots due to her heart condition known as atrial fibrillation. She was taking the blood thinner for five months when she suffered from a life threatening internal bleeding incident that left her with serious injuries. The complaint filed did not detail the exact injuries the plaintiff suffered but it did state that she was left with permanent injuries that will require future care that were a direct result of her uncontrollable internal bleeding.
Xarelto Lawsuit is Filed for Compensation
In the case of the plaintiff in this New York filed case, she is likely to have many medical expenses because of the life saving measures that were required to stop the bleeding and also expenses for the long term medical care needed because of her new condition. The plaintiff is also likely to file damages for loss of income, pain and suffering, and mental damage caused by the incident.
“We encourage all patients who have been harmed by Xarelto to speak with a lawyer about a potential lawsuit,” attorney Marc Goldich says, “By filing a lawsuit, you can begin the process of recovery and pursue justice for what you and your family endured through no fault of your own.”
For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.